Institute for Research in Biomedicine

Institute for
Research
in Biomedicine

Contacts

Inside

News

Events

IRB Community

Support our research

Contacts

Inside

News

Events

IRB Community

Support our research

News

Engineered bacteria for cancer immunotherapy

New SNSF grants awarded to three IRB researchers

First peptide inhibitor of the CXCL12/HMGB1 heterocomplex identified

The Association Bellinzona Institutes of Science (Bios+) is born

IRB ready for clinical testing of second generation antibody against COVID-19

A Single Vaccine Against Coronaviruses is a step closer

Liver disease associated to alpha1-antitrypsin deficiency: a paper by Molinari’s lab published in the EMBO Journal uncovers the signals encoding clearance of ATZ polymers

LICTOR, a new powerful tool to prevent systemic light-chain amyloidosis

Prof. Petr Cejka appointed member of EMBO

Immunologists decipher the recognition of SARS-CoV-2 by CD4+ T lymphocytes in COVID-19 recovered patients

The Ernst Jung Gold Medal for Medicine conferred to Prof. Antonio Lanzavecchia

New paper from the Cavalli’s lab: computational identification of an allosteric binding site in TMPRSS2

Institute for Research in Biomedicine

Istituto di Ricerca in Biomedicina

Via Francesco Chiesa 5
6500 Bellinzona, Switzerland 
Tel. +41 58 666 7000
Fax +41 

Stay in touch

Facebook / Twitter

© Istituto di Ricerca in Biomedicina

Solution by Latitude 46
News / Events / Research Groups / People / Teaching / About Us / Media and communications / Reports / How to support our research / Inside / Contact and directions
up